Sai Life Sciences’ unlisted shares traded at Rs 577 on Tuesday in the grey market, indicating a 5.1% premium over the IPO price band’s upper limit of Rs 549.
Cash takes centre stage as investors rethink AI spending boom
Investors are increasingly focused on technology companies’ cash generation capabilities to fund artificial intelligence investments. Microsoft and Oracle are gaining positive attention from investors, while